Endothelium-derived hyperpolarizing factor - A critical appraisal

Progress in Drug Research

Volumn 50, Issue , 1998, Pages 107-133

  Edwards, Gillian ^a   Weston, Arthur H ^a,b,c,d,e  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d KYUSHU UNIVERSITY   (Japan)

^e G38 Stopford Building   (United Kingdom)

Author keywords

Adenosine triphosphate sensitive potassium channel; Anandamide; Apamin; Charybdotoxin; Endothelium derived hyperpolarizing factor; Endothelium derived relaxing factor; Epoxyeicosatrienoic acid; Iberiotoxin; Large conductance, calcium sensitive potassium channel; Na K ATPase; Nitric oxide; Prostacyclin; Small conductance, calcium sensitive potassium channel

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM); ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ANANDAMIDE; APAMIN; ARACHIDONIC ACID; BRADYKININ; CANNABINOID RECEPTOR; CHARYBDOTOXIN; CLOTRIMAZOLE; CYCLIC AMP; CYCLIC GMP DERIVATIVE; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLIBENCLAMIDE; GUANYLATE CYCLASE; HISTAMINE; ICOSATRIENOIC ACID; MUSCARINIC RECEPTOR; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROADIFEN; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; RIMONABANT; UNINDEXED DRUG;

CALCIUM TRANSPORT; HYPERPOLARIZATION; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0031811498     PISSN: 0071786X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-0348-8833-2_2     Document Type: Review

References (111)

1. H. Kuriyama and H. Suzuki: Br. J. Pharmacol. 64, 493-501 (1978).
2. K. Kitamura and H. Kuriyama: J. Physiol. 293, 119-133 (1979).
3. R.F. Furchgott and J.V. Zawadzki: Nature 288, 373-376 (1980).
4. T.B. Bolton, R.J. Lang and T. Takewaki: J. Physiol. 351, 549-572 (1984).
5. R.F. Furchgott: Acta Physiol. Scand. 139, 257-270 (1990).
6. S.G. Taylor, J.S. Southerton, A.H. Weston and J.R. Baker: Br. J. Pharmacol. 94, 853-863 (1988).
7. A.H. Weston, S.G. Taylor, J.S. Southerton, K.M. Bray, D.T. Newgreen and A.D. McHarg, in: J.A. Bevan, H. Majewski, R.A. Maxwell and D.F. Story (eds.): Vascular Neuroeffector Mechanisms, Vol 10, IRL Press, Oxford 1988, pp. 193-200.
8. S.G. Taylor and A.H. Weston: Trends Pharmacol. Sci. 9, 272-274 (1988).
9. C.J. Garland, F. Plane, B.K. Kemp and T.M. Cocks: Trends Pharmacol. Sci. 16, 23-30 (1995).
10. D.S. Bredt and S.H. Snyder: Ann. Rev. Biochem. 63, 175-195 (1994).
11. T. Itoh, Y. Kanmura, H. Kuriyama and T. Sasaguri: Br. J. Pharmacol. 84, 393-406 (1985).
12. M. Vrolix, L. Raeymaekers, F. Wuytack, F. Hofmann and R. Casteels: Biochem. J. 255, 855-863 (1988).
13. G. Siegel, G. Stock, F. Schnalke and B. Litza, in: R.J. Gryglewski and G. Stock (eds.): Prostacyclin and Its Stable Analogue Iloprost, Springer-Verlag, Berlin 1987, pp. 143-149.
14. M. Tare, H.C. Parkington, H.A. Coleman, T.O. Neild and G.J. Dusting: Nature 346, 69-71 (1990).
15. H.C. Parkington, M. Tare, M.A. Tonta and H.A Coleman: J. Physiol. 465, 459-476 (1993).
16. H.C. Parkington, M.A. Tonta, H.A. Coleman and M. Tare: J. Physiol. 484, 469-480 (1995).
17. M.E. Murphy and J.E. Brayden: J. Physiol. 486, 47-58 (1995).
18. B. Robertson and D.G. Owen: Br. J. Pharmacol. 109, 725-735 (1993).
19. M. Kubo, Y. Nakaya, S. Matsuoka, K. Saito and Y. Kuroda: Circ. Res. 74, 471-476 (1994).
20. V.M. Bolotina, S. Najibi, J.J. Palacino, P.J. Pagano and R.A. Cohen: Nature 368, 850-853 (1994).
21. S.L. Archer, J.M.C. Huang, H.L. Reeve, V. Hampl, S. Tolarova, E. Michelakis and E.K. Weir: Circ. Res. 78, 431-442 (1996).
22. P.M. Zygmunt, T. Ryman and E.D. Högestätt: Acta Physiol. Scand. 155, 257-266 (1995).
23. R.A. Cohen, F. Plane, S. Najibi, I. Huk, T. Malinski and C.J. Garland: Proc. Natl. Acad. Sci. USA 94, 4193-4198 (1997).
24. M.E. Murphy and J.E. Brayden: J. Physiol. 489, 723-734 (1995).
25. G. Chen, H. Suzuki and A.H. Weston: Br. J. Pharmacol. 95, 1165-1174 (1988).
26. A.H. Huang, R. Busse and E. Bassenge: Naunyn Schmiedeberg's Arch. Pharmacol. 338, 438-442 (1988).
27. E. Nishiye, K. Nakao, T. Itoh and H. Kuriyama: Br. J. Pharmacol. 96, 645-655 (1989).
28. C.J. Garland and G.A. McPherson: Br. J. Pharmacol. 105, 429-435 (1992).
29. E.V. Kilpatrick and T.M. Cocks: Br. J. Pharmacol. 112, 557-565 (1994).
30. A.I. McCulloch, F.E. Bottrill, M.D. Randall and C.R. Hiley: Br. J. Pharmacol. 120, 1431-1438 (1997).
31. M. Félétou and P.M. Vanhoutte: Br. J. Pharmacol. 93, 515-524 (1988).
32. G.F. Chen and H. Suzuki: Am. J. Physiol. 260, H1037-H1042 (1991).
33. F. Plane, T. Pearson and C.J. Garland: Br. J. Pharmacol. 115, 31-38 (1995).
34. M. Hecker, A. Mülsch, E. Bassenge and R. Busse: Am. J. Physiol. 265, H828-H833 (1993).
35. J.V. Mombouli, I. Bissiriou, V.D. Agboton and P.M. Vanhoutte: Biochem. Biophys. Res. Commun. 221, 484-488 (1996).
36. J.L. Bény: Eur. J. Pharmacol. 185, 235-238 (1990).
37. L. Missiaen, H. De Smed, J.B. Parys, I. Sienaert, S. Valingen and R. Casteels: J. Biol. Chem. 271, 12287-12293 (1996).
38. K. Fujii, M. Tominaga, S. Ohmori, K. Kobayashi, T. Koga, Y. Takata and M. Fujishima: Circ. Res. 70, 660-669 (1992).
39. G.A. McPherson and J.A. Angus: Br. J. Pharmacol. 103, 1184-1190 (1991).
40. H. Hashitani and H. Suzuki: J. Physiol. 501, 319-329 (1997).
41. P.M. Zygmunt, K. Waldeck and E.D. Högestätt: Acta Physiol. Scand. 152, 375-384 (1994).
42. J. Petersson, P.M. Zygmunt and E.D. Högestätt: Br. J. Pharmacol. 120, 1344-1350 (1997).
43. C.L. Cowan, J.J. Palacino, S. Najibi and R.A. Cohen: J. Pharmacol. Exp. Ther. 266, 1482-1489 (1993).
44. D. Fulton, J.C. McGiff and J. Quilley: Br. J. Pharmacol. 113, 954-958 (1994).
45. V. Lischke, R. Busse and M. Hecker: Br. J. Pharmacol. 135, 969-974 (1995a).
46. K.G. Chandy and G.A. Gutman, in: R. A. North (ed.): Ligand and Voltage-Gated Ion Channels, CRC Press, London 1995, pp. 1-71.
47. P.M. Zygmunt and E.D. Högestätt: Br. J. Pharmacol. 117, 1600-1606 (1996).
48. M.L. Garcia, M. Hanner, H.G. Knaus, R. Koch, W. Schmalhofer, R.S. Slaughter and G.J. Kaczorowski: Advances in Pharmacology, 39, 425-471 (1997).
49. R. Popp, J. Bauersachs, M. Hecker, I. Fleming and R. Busse: J. Physiol. 497, 699-709 (1996).
50. J. Daut: J. Physiol. 502, 469 (1997).
51. P.M. Zygmunt, G. Edwards, A.H. Weston, B. Larsson and E.D. Högestätt: Br. J. Pharmacol. 121, 141-149 (1997).
52. A.S. Adeagbo and C.R. Triggle: J. Cardiovasc. Pharmacol. 21, 423-429 (1993).
53. M. Hecker, A.T. Bara, J. Bauersachs and R. Busse: J. Physiol. 481, 407-414 (1994).
54. A. García-Pascual, A. Labadia, E. Jimenez and G. Costa: Br. J. Pharmacol. 115, 1221-1230 (1995).
55. N. Yamakawa, M. Ohhashi, S. VVaga and T. Itoh: Br. J. Pharmacol. 121, 1315-1322 (1997).
56. F. Vogalis and R.K. Goyal: J. Physiol. 502, 497-508 (1997).
57. C. Van Renterghem and M. Lazdunski: Pflugers Arch. 420, 417-423 (1992).
58. S.M. Marchenko and S.O. Sage: J. Physiol. 492, 53-60 (1996).
59. K. Muraki, Y. Imaizumi, S. Ohya, K. Sato, T. Takii, K. Onozaki and M. Watanabe: Biochem. Biophys. Res. Commun. 236, 340-343 (1997).
60. G.J. Waldron and C.J. Garland: Can. J. Physiol. Pharmacol. 72 (suppl. 1), 115 (1994).
61. C. Corriu, M. Félétou, E. Canet and P.M. Vanhoutte: Br. J. Pharmacol. 119, 959-964 (1996).
62. W.B. Campbell, D. Gebremedhin, P.P. Pratt PF and D.R. Harder: Circ. Res. 78, 415-423 (1996).
63. G.F. Chen and D.W. Cheung: Circ. Res. 79, 827-833 (1996).
64. G.E. Revtyak, A.R. Johnson and W.B. Campbell: Am. J. Physiol. 254, C8-C19 (1988).
65. K.A. Pritchard Jr, R.R. Tota, M.B. Stemerman and P.Y. Wong: Biochem. Biophys. Res. Commun. 167, 137-142 (1990).
66. M. Rosolowsky, J.R. Falck and W.B. Campbell: Adv. Prostaglandin Thromb. Res. 21, 213-216 (1990).
67. M. Rosolowsky and W.B. Campbell: Biochim. Biophys. Acta 1299, 267-277 (1996).
68. D. Gebremedhin, Y.-H. Ma, J.R. Falck, R.J. Roman, M. Van Rollins and D.R. Harder: Am. J. Physiol. 263, H519-H525 (1992).
69. P.L. Li, A.P. Zou and W.B. Campbell: Hypertension 29, 262-267 (1997).
70. J.C. McGiff: Annu. Rev. Pharmacol. Toxicol. 31, 339-369 (1991).
71. W.F. Graier, S. Simecek and M. Sturek: J. Physiol. 482, 259-274 (1995).
72. B.G. Hoebel, G.M. Kostner and W.F. Graier: Br. J. Pharmacol. 121, 1579-1588 (1997).
73. P.L. Li and W.B. Campbell: Circ. Res. 80, 877-884 (1997).
74. K.G. Proctor, J.R. Falck and A.J. Capdevila: Circ. Res. 60, 50-59 (1987).
75. P.M. Zygmunt, G. Edwards, A.H. Weston, S.C. Davis and E.D. Högestätt: Br. J. Pharmacol. 118, 1147-1152 (1996).
76. M.D. Randall, S.P.H. Alexander, T. Bennett, E.A. Boyd, J.R. Fry, S.M. Gardiner, P.A. Kemp, A.I. McCulloch and D.A. Kendall: Biochem. Biophys. Res. Commun. 229, 114-120 (1996).
77. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger and R. Mechoulam: Science 258, 1946-1949 (1992).
78. S. Munro, K.L. Thomas and M. Abu-Shaar: Nature 365, 61-65 (1993).
79. R.G. Pertwee: Pharmacol. Ther. 74, 129-180 (1997).
80. E.J. Ishac, L. Jiang, K.D. Lake, K. Varga, M.E. Aboo and G. Kunos: Br. J. Pharmacol. 118, 2023-2028 (1996).
81. R.G. Pertwee and S.R. Fernando: Br.J. Pharmacol. 118, 2053-2058 (1996).
82. V. Di Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.C. Schwartz and D. Piomelli: Nature 372, 686-691 (1994).
83. F. Plane, M. Holland, G.J. Waldron, C.J. Garland and J.P. Boyle: Br.J. Pharmacol. 121, 1509-1511 (1997).
84. R. White and C.R. Hiley: Br. J. Pharmacol. 122, 1573-1584 (1997).
85. M. Rinaldi-Carmona, F. Barth, M. Héaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Néliat, D. Caput, P. Ferrara, P. Soubrié, J. C. Brelière, G. Le Fur: FEBS Lett. 350, 240-244 (1994).
86. V. M. Showalter, D. R. Compton, B. R. Martin and M. E. Abood: J. Pharmacol. Exp. Ther. 278, 989-999 (1996).
87. T. Chataigneau, C. Thollon, J.-P. Iliou, M. Félétou, J.-P. Vilaine, J. Duhault and P.M. Vanhoutte: J. Vasc. Res. 34 (Suppl. 1), 10 (1997).
88. P.M. Zygmunt, E.D. Högestätt, K. Waldeck, G. Edwards, A.J. Kirkup and A.M. Weston: Br. J. Pharmacol. 122, 1679-1686 (1997).
89. W. R. Kukovetz, W. F. Graier and K. Groschner: Jpn. J. Pharmacol. 58, 213P-219P (1992).
90. K. Groschner, W. F. Graier and W. R. Kukovetz: Biochim. Biophys. Acta 1137, 162-170 (1992).
91. K. Groschner, W. F. Graier and W. R. Kukovetz: Circ. Res. 75, 304-314 (1994).
92. A. Lückhoff and R. Busse: Naunyn Schmiedeberg's Arch. Pharmacol. 342, 94-99 (1990).
93. P.C. Brunet and J.L. Bény: Blood Vessels 26, 228-234 (1989).
94. T.L. Little, J. Xia and B.R. Duling: Circ. Res. 76, 498-504 (1995).
95. J.L. Bény and F. Chabaud, in: P. M. Vanhoutte (ed.): Endothelium-Derived Hyperpolarizing Factor, Harwood Academic Publishers GmbH, Amsterdam 1996, pp.41-49.
96. E. Kühberger, K. Groschner, W.R. Kukovetz and F. Brunner: Br. J. Pharmacol. 113, 1289-1294 (1994).
97. G. Schmilinsky-Fluri, V. Valiunas, M. Willi, R. Weingart: J. Mol. Cell. Cardiol. 29, 1703-1713 (1997).
98. A.G. Knapp and J.E. Dowling: Nature 325, 437-439 (1987).
99. S. H. DeVries and E. A. Schwartz: J. Physiol. 414, 351-375 (1989).
100. E. Miyachi, M. Murakami and T. Nakaki: NeuroReport 1, 107-110 (1990).
101. C.B. Lu and D.G. McMahon DG: J. Physiol. 499, 689-699 (1997).
102. J. Bauersachs, R. Popp, M. Hecker, E. Sauer, I. Fleming and R. Busse: Circulation 94, 3341-3347 (1996).
103. J.L. Bény: Pflugers Arch. 433, 364-367 (1997).
104. J.L. Bény and C. Pacicca: Am. J. Physiol. 266, H1465-1472 (1994).
105. G. Chen, H. Hashitani and H. Suzuki: Br. J. Pharmacol. 98, 950-956 (1989).
106. K. Bray and U. Quast: Br. J. Pharmacol. 102, 585-594 (1991).
107. F.J. Haddy: Clin. Invest. Med. 10, 547-554 (1987).
108. J.G. McCarron and W. Halpern: Am. J. Physiol. 259, H902-H908 (1990).
109. H.M. Prior, N. Webster, K. Quinn, D.J. Beech and M.S. Yates: Cardiovasc. Res., in press 1998.
110. P.M. Zygmunt: PhD Thesis, Lund University, Sweden 1995.
111. Progress in Drug Research, Vol. 50 (E. Jucker, Ed.)